Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ et al (2014) Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost 40:724–735. https://doi.org/10.1055/s-0034-1390325
Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M et al (2015) Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 36:605–614. https://doi.org/10.1093/eurheartj/ehu218
Article CAS PubMed Google Scholar
Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P et al (2014) Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 311:2414–2421. https://doi.org/10.1001/jama.2014.5990
Article CAS PubMed Google Scholar
Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507–511. https://doi.org/10.1016/0140-6736(93)90274-k
Article CAS PubMed Google Scholar
Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O et al (1992) PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 20:520–526. https://doi.org/10.1016/0735-1097(92)90002-5
Article CAS PubMed Google Scholar
Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ (1997) Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 80:184–188. https://doi.org/10.1016/s0002-9149(97)00315-9
Article CAS PubMed Google Scholar
Sista AK, Goldhaber SZ, Vedantham S, Kline JA, Kuo WT, Kahn SR et al (2016) Research priorities in submassive pulmonary embolism: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 27:787–794. https://doi.org/10.1016/j.jvir.2016.03.035
Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J et al (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411. https://doi.org/10.1056/NEJMoa1302097
Article CAS PubMed Google Scholar
Kahn SR, Akaberi A, Granton JT, Anderson DR, Wells PS, Rodger MA et al (2017) Quality of life, dyspnea, and functional exercise capacity following a first episode of pulmonary embolism: results of the ELOPE cohort study. Am J Med 130:990–990. https://doi.org/10.1016/j.amjmed.2017.03.033
Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J et al (2017) Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 69:1536–1544. https://doi.org/10.1016/j.jacc.2016.12.039
Article CAS PubMed Google Scholar
Giri J, Sista AK, Weinberg I, Kearon C, Kumbhani DJ, Desai ND et al (2019) Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation 140:e774. https://doi.org/10.1161/CIR.0000000000000707
Tu T, Toma C, Tapson VF, Adams C, Jaber WA, Silver M et al (2019) A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC Cardiovasc Interv 12:859–869. https://doi.org/10.1016/j.jcin.2018.12.022
Toma C, Khandhar S, Zalewski AM, D’Auria SJ, Tu TM, Jaber WA (2020) Percutaneous thrombectomy in patients with massive and very high-risk submassive acute pulmonary embolism. Catheter Cardiovasc Interv 96:1465–1470. https://doi.org/10.1002/ccd.29246
Schell R, Alban F, Frey N, Erbel C (2026) Mechanical thrombectomy reduces increased high sensitivity troponin levels in intermediate-high risk pulmonary embolism. Heart Lung Circ 35:259–270. https://doi.org/10.1016/j.hlc.2025.08.023
Buckley JR, Wible BC (2022) In-hospital mortality and related outcomes for elevated risk acute pulmonary embolism treated with mechanical thrombectomy versus routine care. J Intensive Care Med 37:877–882. https://doi.org/10.1177/08850666211036446
Toma C, Bunte MC, Cho KH, Jaber WA, Chambers J, Stegman B et al (2022) Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: interim results of the FLASH registry. Catheter Cardiovasc Interv 99:1345–1355. https://doi.org/10.1002/ccd.30091
Article PubMed PubMed Central Google Scholar
Lauder L, Perez Navarro P, Gotzinger F, Ewen S, Al Ghorani H, Haring B et al (2023) Mechanical thrombectomy in intermediate- and high-risk acute pulmonary embolism: hemodynamic outcomes at three months. Respir Res 24:257. https://doi.org/10.1186/s12931-023-02552-w
Article PubMed PubMed Central Google Scholar
Saleh H, Khaleel I, Kerndt C, Weber P, Hollowell M, McCalmon C et al (2025) Outcomes in patients with pulmonary embolism treated with mechanical thrombectomy or anticoagulation alone. J Soc Cardiovasc Angiogr Interv 4:102611. https://doi.org/10.1016/j.jscai.2025.102611
Article PubMed PubMed Central Google Scholar
Jaber WA, Gonsalves CF, Stortecky S, Horr S, Pappas O, Gandhi RT et al (2025) Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial. Circulation 151:260–273. https://doi.org/10.1161/CIRCULATIONAHA.124.072364
Article CAS PubMed Google Scholar
Harjola VP, Mebazaa A, Celutkiene J, Bettex D, Bueno H, Chioncel O et al (2016) Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 18:226–241. https://doi.org/10.1002/ejhf.478
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP et al (2020) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603. https://doi.org/10.1093/eurheartj/ehz405
Roeleveld RJ, Marcus JT, Faes TJ, Gan TJ, Boonstra A, Postmus PE et al (2005) Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 234:710–717. https://doi.org/10.1148/radiol.2343040151
Lurz P, Puranik R, Nordmeyer J, Muthurangu V, Hansen MS, Schievano S et al (2009) Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J 30:2266–2274. https://doi.org/10.1093/eurheartj/ehp258
Nagueh SF, Sanborn DY, Oh JK, Anderson B, Billick K, Derumeaux G et al (2025) Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: an update from the American Society of Echocardiography. J Am Soc Echocardiogr 38:537–569. https://doi.org/10.1016/j.echo.2025.03.011
Bowers T, Goldstein JA (2021) Hemodynamic compromise in pulmonary embolism: “a tale of two ventricles.” Catheter Cardiovasc Interv 97:299–300. https://doi.org/10.1002/ccd.29497
Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK et al (2018) Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation 137:e578–e622. https://doi.org/10.1161/CIR.0000000000000560
Naeije R, Badagliacca R (2017) The overloaded right heart and ventricular interdependence. Cardiovasc Res 113:1474–1485. https://doi.org/10.1093/cvr/cvx160
Article CAS PubMed Google Scholar
Friedberg MK, Redington AN (2014) Right versus left ventricular failure: differences, similarities, and interactions. Circulation 129:1033–1044. https://doi.org/10.1161/CIRCULATIONAHA.113.001375
Santamore WP, Dell’Italia LJ (1998) Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Prog Cardiovasc Dis 40:289–308. https://doi.org/10.1016/s0033-0620(98)80049-2
Comments (0)